TIP
ABBV icon

Torray Investment Partners’s AbbVie ABBV Stock Holding History

Torray Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.4M Buy
93,588
+901
+1% +$200K 2.99% 13
2025
Q4 		$21.2M Sell
92,687
-8,945
-9% -$2.04M 3.03% 10
2025
Q3 		$23.5M Buy
101,632
+6,590
+7% +$1.34M 3.19% 5
2025
Q2 		$17.6M Buy
95,042
+69,195
+268% +$12.9M 2.56% 13
2025
Q1 		$5.42M Sell
25,847
-4,824
-16% -$938K 0.81% 45
2024
Q4 		$5.45M Buy
30,671
+9,107
+42% +$1.67M 0.78% 46
2024
Q3 		$4.26M Buy
21,564
+20
+0.1% +$3.73K 0.6% 52
2024
Q2 		$3.7M Buy
21,544
+293
+1% +$48.5K 0.55% 56
2024
Q1 		$3.87M Buy
21,251
+650
+3% +$112K 0.58% 52
2023
Q4 		$3.19M Sell
20,601
-589
-3% -$85.9K 0.52% 54
2023
Q3 		$3.16M Buy
21,190
+2,446
+13% +$359K 0.56% 54
2023
Q2 		$2.53M Buy
18,744
+27
+0.1% +$3.96K 0.44% 59
2023
Q1 		$2.98M Buy
18,717
+229
+1% +$35K 0.54% 55
2022
Q4 		$2.99M Buy
18,488
+239
+1% +$36.6K 0.54% 55
2022
Q3 		$2.45M Buy
18,249
+1,217
+7% +$175K 0.49% 54
2022
Q2 		$2.61M Buy
17,032
+206
+1% +$31.5K 0.5% 59
2022
Q1 		$2.73M Sell
16,826
-3,703
-18% -$538K 0.44% 61
2021
Q4 		$2.78M Buy
20,529
+776
+4% +$91.7K 0.41% 59
2021
Q3 		$2.13M Buy
19,753
+228
+1% +$26.1K 0.33% 61
2021
Q2 		$2.2M Sell
19,525
-65
-0.3% -$7.32K 0.32% 62
2021
Q1 		$2.12M Sell
19,590
-21
-0.1% -$2.25K 0.33% 58
2020
Q4 		$2.1M Sell
19,611
-986
-5% -$94.8K 0.35% 55
2020
Q3 		$1.8M Buy
20,597
+108
+0.5% +$10.2K 0.33% 59
2020
Q2 		$2.01M Sell
20,489
-2,765
-12% -$243K 0.38% 53
2020
Q1 		$1.77M Sell
23,254
-6,095
-21% -$519K 0.39% 53
2019
Q4 		$2.6M Sell
29,349
-463
-2% -$38.4K 0.45% 54
2019
Q3 		$2.26M Buy
29,812
+276
+0.9% +$18.9K 0.25% 59
2019
Q2 		$2.15M Buy
29,536
+2,583
+10% +$203K 0.22% 62
2019
Q1 		$2.17M Buy
26,953
+2,707
+11% +$221K 0.23% 57
2018
Q4 		$2.23M Buy
24,246
+3,787
+19% +$333K 0.27% 57
2018
Q3 		$1.94M Buy
20,459
+2,645
+15% +$251K 0.19% 64
2018
Q2 		$1.65M Buy
17,814
+2,584
+17% +$252K 0.17% 66
2018
Q1 		$1.44M Sell
15,230
-869
-5% -$95.5K 0.15% 69
2017
Q4 		$1.56M Buy
16,099
+1,714
+12% +$162K 0.15% 67
2017
Q3 		$1.28M Buy
14,385
+740
+5% +$56.3K 0.13% 66
2017
Q2 		$989K Buy
13,645
+2,220
+19% +$149K 0.1% 67
2017
Q1 		$744K Buy
11,425
+1,635
+17% +$103K 0.08% 69
2016
Q4 		$613K Buy
9,790
+740
+8% +$45.2K 0.07% 96
2016
Q3 		$571K Hold
9,050
– – 0.06% 69
2016
Q2 		$560K Buy
+9,050
New +$551K 0.04% 69

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Torray Investment Partners's ABBV Position: Q1 2026 in Review

Torray Investment Partners increased its AbbVie (ABBV) stake by 0.97% in Q1 2026, buying an estimated $200K and bringing the position to 93,588 shares worth $20.4M. The position accounts for 2.99% of the portfolio, ranked #13.

Torray Investment Partners first reported a position in ABBV in Q2 2016 and has held it in 40 quarters since. The position peaked at $23.5M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Torray Investment Partners held 93,588 shares of AbbVie worth $20.4M as of Q1 2026.
  • Torray Investment Partners bought 901 AbbVie shares in Q1 2026, an estimated $200K.
  • AbbVie made up 2.99% of Torray Investment Partners's portfolio in Q1 2026, its #13 holding.
  • Torray Investment Partners first reported a position in AbbVie in Q2 2016 and has held it in 40 quarters since.
  • Torray Investment Partners's AbbVie position peaked at $23.5M in Q3 2025.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Torray Investment Partners's 13F filing for Q1 2026, filed 1 May 2026.